Published Feb. 5, 2026

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and celebrate an exciting milestone for Dr. Pritt’s “Creepy Dreadful Wonderful Parasites” blog. Later in the episode, Dr. Pritt welcomes Angie Reese-Davis, Mayo Clinic Laboratories’ director of operations, to explore how proactive monitoring, shipping workflows, teamwork, and ongoing process improvements all contribute to a resilient lab logistics system.

• PAMA reform update (00:34): Get the latest on PAMA delays and the new Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
• Creepy Dreadful Wonderful Parasites (04:24): Go behind the scenes of the 800 parasite cases Dr. Pritt has featured on her long-running blog.
• Logistics at Mayo Clinic Laboratories (08:09): Learn how the team manages and tracks the 40,000 samples that arrive each day.
• Process improvement and resiliency (12:49): Discover how the logistics team continues to innovate and evolve to support clients more efficiently and effectively.

Note: Information in this post was accurate at the time of its posting.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:

• JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year’s conference.
• Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.
• Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics.

Note: Information in this post was accurate at the time of its posting.

Resources

• Transforming laboratory medicine through AI: From promise to practice
• "Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025
• "Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss direct-to-consumer testing. Then, Dr. Pritt welcomes Matthew Binnicker, Ph.D., a microbiologist and virologist and chief scientific officer of Mayo Clinic Laboratories, for a conversation about accelerating innovation without compromising quality or safety.

• Direct-to-consumer testing (00:38): Explore the rise of direct-to-consumer testing and the challenges that accompany it.
• Evolving expectations for innovation (05:38): Understand why patient and clinician expectations are rising and how that is reshaping diagnostics.
• Safeguarding advances (07:23): Learn the foundational principles that protect quality and safety amid rapid innovation.
• Strategies for accelerating innovation (10:33): Discover practical ways to responsibly deliver novel solutions more quickly.

Note: Information in this post was accurate at the time of its posting.

Resources

• Five ways to move faster without compromising trust in diagnostics
• "Answers From the Lab” podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025
• 360Dx: 2025 highlights and takeaways for the clinical lab industry